Association of plasma somatostatin with disease severity and progression in patients with autosomal dominant polycystic kidney disease

Author(s):: Messchendorp, A.L.; Spithoven, E.M.; Casteleijn, N.F.; Dam, W.A.; Born, J. van den; Tonnis, W.F.; Gaillard, C.A.J.M.; Meijer, E.; Drenth, J.; Fijter, J.W. de; Gansevoort, R.T.; Peters, D.J.M. (0000-0001-6974-7143); Wetzels, J.F.M.; Zietse, R.; DIPAK Consortium

Published: 2018
Publication type: Article / Letter to editor

ADPKDSomatostatinBiomarkercAMPDisease progression

Date issued: 2018-12-19
Language: English
Is part of: BMC Nephrology
hdl: 1887/86536
doi: 10.1186/s12882-018-1176-y
URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6299932/pdf/12882_2018_Article_1176.pdf